User Tools

Site Tools


research:project_proposal_template

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
Last revision Both sides next revision
research:project_proposal_template [2014/12/02 18:21]
jduke
research:project_proposal_template [2015/02/16 20:45]
rkboyce
Line 1: Line 1:
- +====== ​Incidence of exposure to drugs for which pre-emptive pharmacogenomic testing is available  ​======
-To create a new study, login to the Wiki and then: +
- +
-1) Click the Edit (Pencil) button to the right of this page.  Copy all the text.   +
- +
-2) Go to the [[research:​protocols_in_development|Protocols under Development]] page. Click Edit. +
- +
-3) Add the name of your study to the list.  Hit Save. +
- +
-4) Click on your new study'​s page.  Hit edit.  Paste in the text you copied and edit away! +
- +
-====== ​<Your Study Name>======+
  
 <WRAP box justify round> <WRAP box justify round>
  
-**Objective:​** //<​summarize study objective>//​+**Objective:​** ​Derive data that large healthcare organizations can combine data on risks of adverse events ​ and cost data to conduct cost-effectiveness ​cost-benefit analyses for pre-emptive pharmacogenomics testing
  
-**Rationale:​** ​//<​summarize ​study rationale>//​+**Rationale:​** ​Very few studies have been conducted that report on the potential return on investment for pre-emptive pharmacogenomics testing. The studies that have been published ​ suggest that pre-emptive pharmacogenomics testing may produce a return on investment but much depends on if a sufficient number of drugs with pharmacogenes are covered by a single test. Since the current data are limited to relatively localized settings and might not be of generalizable use to other health organizations,​ it's of interest to implement a new study using the OHDSI research network. ​
  
-**Project Lead(s):​** ​//<​initial proposerslist may grow>//+**Project Lead(s):​** ​Richard D. BoyceMatthias Samwald, (seeking other collaborators)
  
-**Coordinating Institution(s):​** ​//<your institution>//​+**Coordinating Institution(s):​** ​University of Pittsburgh, Medical University of Vienna
  
 ** Additional Participants:​** ​ //<​usually blank initially, list will grow as individuals are added who are not project leads>// ** Additional Participants:​** ​ //<​usually blank initially, list will grow as individuals are added who are not project leads>//
Line 26: Line 15:
 **Full Protocol:** //<if available, a link to protocol. ​ not necessary for initial planning>//​ **Full Protocol:** //<if available, a link to protocol. ​ not necessary for initial planning>//​
  
-**Initial Proposal Date:​**  ​+**Initial Proposal Date:​**  ​2/16/2015
  
 **Launch Date:​** ​ //<fill out once finalized>//​ **Launch Date:​** ​ //<fill out once finalized>//​
Line 37: Line 26:
  
 ===== Requirements ===== ===== Requirements =====
-**CDM:​** ​//<V4 or V5 or both>//+**CDM:** V4 or V5
  
-**Table Accessed:​**  ​//<e.g.persondrug_exposureobservations>//​+**Table Accessed:​**  ​DRUG_EXPOSURECONCEPT_ANCESTORCONCEPT_RELATIONSHIPPERSON
  
 **Database Dialects:** SQL Server, Postgres, Oracle **Database Dialects:** SQL Server, Postgres, Oracle
  
-**Software:​** ​ //<<​e.g., ​R>// ​+**Software:​** ​SQL and 
    
 ===== Code =====  ===== Code ===== 
-[[https://​github.com/​OHDSI/​StudyProtocols]]+[[https://​github.com/​OHDSI/​StudyProtocols/​tree/​master/​Proposed%20Study%203%20-%20Incidence%20of%20exposure%20to%20PGx%20drugs|GitHub code for Proposed Study 3 - Incidence of exposure to PGx drugs]]
  
 ===== Discussion =====  ===== Discussion ===== 
Line 52: Line 41:
  
 ===== Datasets Run =====  ===== Datasets Run ===== 
-  * <list your own datasets or leave blank>+  * Truven CCAE in the IMEDS lab 
 +  * Truven MDCD in the IMEDS lab 
 +  * Truven MDCR in the IMEDS lab
  
  
 ~~NOTOC~~ ~~NOTOC~~
research/project_proposal_template.txt · Last modified: 2015/02/16 20:45 by rkboyce